Axio Biosolutions, a biomaterial focused medtech company today announced the US Food and Drug Administration (FDA) 510(k) clearance for its latest innovation, Ax-Surgi Surgical Hemostat. With this, Ax-surgi has become the first and only chitosan-based hemostat cleared for controlling severe surgical bleeding. Ax-Surgi is based on